Friday November 27 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Seikagaku Corporation

Nil


Contact Details:
Tel:
Fax:
Email:
WWW:

www.seikagaku.co.jp/




Recent Publications by Seikagaku Corporation:

Generation and characterization of a series of monoclonal antibodies that specifically recognize [HexA(+/-2S)-GlcNAc]n epitopes in heparan sulfate.
Five monoclonal antibodies AS17, 22, 25, 38 and 48, a single monoclonal...
5th February, 2009
Central Research Laboratories, Seikagaku Corporation, 3-1253 Tateno, Glycoconj J. 2008 Nov;25(8):703-12. Epub 2008 May 7.
DOI Direct Link
Tetrasulfated disaccharide unit in heparan sulfate: enzymatic formation and tissue distribution.
We previously reported that the heparan sulfate 3-O-sulfotransferase...
24th December, 2008
Central Research Laboratories, Seikagaku Corporation, 3-1253 Tateno, J Biol Chem. 2008 Nov 7;283(45):31237-45. Epub 2008 Aug 28.
DOI Direct Link
Analytical method to determine keratan sulfate in the serum using HPLC.
There is an established method to assess the extent of articular cartilage...
30th July, 2008
Seikagaku Corporation, Yokosuka. Rinsho Byori. 2008 May;56(5):373-8.
Identification of N-glycan-binding proteins for E3 ubiquitin ligases.
N-glycans serve as a degradation signal by the SCF(Fbx2) ubiquitin ligase...
6th February, 2007
Seikagaku Corporation, Central Research Laboratories, Tokyo, Japan. Methods Enzymol. 2006;415:20-30.
DOI Direct Link
Application of fluorophore-assisted carbohydrate electrophoresis to analysis of disaccharides and oligosaccharides derived from glycosaminoglycans.
Various combinations of fluorescent dyes, polyacrylamide gels, and...
8th November, 2005
Seikagaku Corporation, Central Research Laboratories, 1253, Tateno Anal Biochem. 2005 Aug 15;343(2):212-22.
DOI Direct Link

View more Seikagaku Corporation research publications.

BioNews Results for Seikagaku Corporation:

Agent for treating inflammatory bowel diseases
PharmCast:  Oct 13 2009 4:09AM Matching: seikagaku

Seikagaku Corporation Patents:

US Patent No.Title
6228998 Amino spacered glycosaminoglycan derivatives and their use in copolymerization with acrylamide
6492503 Glycosaminoglycan and drug compositions containing the same
6498246 Glycosaminoglycan derivatives and processes for preparing same
6537977 Anti-inflammatory agent
6545136 Process for producing desulfated polysaccharide, and desulfated heparin

View more Seikagaku Corporation patents.

BioPortfolio Ltd provides targeted e-mail address lists for the life science sector - we can enable you to contact around 24 individuals from Seikagaku Corporation using this service.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 484 times since April 2007, the link to the organisation's website has been followed 77 times

Recent Search Terms used to find this page: Seikagaku Gel-200 | seikagaku corporation antibodies | gel-200 seikagaku 2009 | seikagaku antibody | gel 200 seikagaku | seikagaku antibody | SEIKAGAKU CORPORATION Legal Department | seikagaku, antibody | seikagaku | monoclonal seikagaku | .



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Seikagaku Corporation

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.